Site icon Holiday Recipes to Cook

“Long QT-syndrome with Sinus Bradycardia”, Victor McKusick, Mendelian Inheritance in Man, 1966. 長QT綜合徵伴有竇性心動過緩。 (LQTS).

Screenshot


Here I present: Long QT-syndrome with Sinus Bradycardia“, Victor McKusick, Mendelian Inheritance in Man’, 1966. 長QT綜合徵伴有竇性心動過緩。(LQTS).

INTRODUCTION.

Congenital long QT syndrome (LQTS) is electrocardiographically characterized by a prolonged QT interval and polymorphic ventricular arrhythmias. These cardiac arrhythmias may result in recurrent syncope, seizure, or sudden death.


Long QT syndrome type-4 can be caused by mutation in the ANK2 gene. Loss-of-function mutations in ANK2 can result in a broad spectrum of clinical cardiac phenotypes. Carriers of some mutations display QT interval prolongation, stress- and/or exercise-induced polymorphic ventricular arrhythmia, syncope, and sudden cardiac death. Patients with other variants show clinical phenotypes, sometimes mild, extending beyond LQTS, leading to the label ‘ankyrin-B syndrome.’ These phenotypes include bradycardia, sinus arrhythmia, delayed conduction/conduction block, idiopathic ventricular fibrillation, and catecholaminergic polymorphic ventricular tachycardia.

There is evidence long QT syndrome type-4 can also be caused by mutation in the ANK2 gene on cytogenetic location 4q25-q26 and genomic coordinates 4:112,705,622-113,383,736. The screenshot of the ANK2 gene 678,115 bp (base pairs) of DNA sequence length is shown BELOW.  Nine (9) other genes besides ANK2 in the 4q25-q26 cytogenetic location are listed BENEATH.

Coordinate  Symbol  Genomic Name
4:112,648,004  MIR302D Micro RNA 302D
4:112,648,183  MIR302A Micro RNA 302A
4:112,648,363  MIR302C Micro RNA 302C
4:112,648,485  MIR302B Micro RNA 302B
4:112,705,622  ANK2 Ankyrin-2, nonerythrocytic
4:113,200,001  SYISL SYNPO2 intron sense long noncoding RNA
4:113,451,032  CAMK2D Calcium/calmodulin protein kinase II-delta
4:113,900,284  ARSJ Arylsulfatase J
4:114,598,402  UGT8 UDP glycosyltransferase 8 
4:114,827,763  NDST4 N-deacetylase/N-sulfotransferase 4

Exit mobile version